omeprazole has been researched along with c-peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Koshelev, D; Kosheleva, L; Lagunas-Rangel, FA; Levit, S; Nedorubov, A; Rabinovitch, A; Schiƶth, HB; Trukhan, V | 1 |
1 other study(ies) available for omeprazole and c-peptide
Article | Year |
---|---|
Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice.
Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; gamma-Aminobutyric Acid; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Omeprazole; Proton Pump Inhibitors; Sitagliptin Phosphate | 2022 |